Introduction
Klebsiella pneumoniae is considered as the main cause of nosocomial infections among Gramnegative bacteria, such as urinary tract, pneumonia, wound, septicemia and bloodstream infections (Arivett et al., 2015) . It is very important to investigate the antimicrobial susceptibility pattern of Klebsiella in order to prevent the rapid spread of drug resistance (Namratha et al., 2015) .
Extended-spectrum β-lactamases (ESBLs), multi-drug resistant K. pneumoniae contains virulence factors that cause treatment failure (Mustafa et al., 2017) . ESBLs can hydrolyze β-lactam ring in β-lactam drugs by a nucleophilic attack (Papp-Wallace et al., 2011 E XTENDED-spectrum β-lactamase (ESBL) producing Klebsiella pneumoniae strains can present resistance to many antibiotic groups due to resistant genes. This study conducted to detect and identify multi-drug resistant (MDR), ESBL producing K. pneumoniae strains from different clinical samples with detection and sequencing of both Temoneira (TEM) and sulfhydryl variable (SHV) genes and using Glycyrrhizic acid nanoparticle as an antimicrobial agent for ESBL producing K. pneumoniae strains. One hundred and fifty clinical specimens were processed. ESBL producing K. pneumoniae strains were detected by double disk synergy test. TEM and SHV genes responsible for MDR in K. pneumoniae were detected by polymerase chain reaction (PCR) and sequence alignment was done using DNA sequencing. The effect of different concentrations of Nano Glycyrrhizic acid was determined. K. pneumoniae was detected in 53.3% of the total collected samples (80/150). Seventy one percent (57/80) of them were found to be multi-drug resistant strains and 63% (36/57) also found to contain the ESBL enzymes. Males were highly infected than females. TEM gene was detected in 52.8% of the ESBL isolates while SHV gene was detected in 72.2%. Twenty Five percent of the ESBL producing K. pneumoniae was found to contain both TEM and SHV genes. Nucleic acid sequence alignment of both genes showed some mutations. Chloramphenicol was found to be the drug of choice to overcome ESBL producing K. pneumoniae with inhibition of 97.2%. The antibacterial activity of Nano Glycyrrhizic acid revealed that 10µg/ml was found to be the minimum bactericidal concentration (MBC) against ESBL producing K. pneumoniae isolates.
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Aminoglycosides (Vuotto et al., 2014) .
The antibiotic treatments against K. pneumoniae infections contain Aminoglycosides group such as Gentamycin, Quinolones group and β-lactams group such as Carbapenems and Cephalosporins (Qureshi, 2015) . Some resistant K. pneumoniae strains can form biofilm that resist against β-lactams, Carbapenems, Trimethoprim/Sulfamethoxazole, Aminoglycosides and Fluoroquinolones (Kumar et al., 2011) . Nanoscale particles and molecules are a potential alternative for treatment of disease based on their structure and size, which differ from traditional small-molecule drugs (Wagner et al., 2006) . Several pharmaceutical companies have obtained approval from the US Food and Drug M. ABDEL-MONGY et al.
Administration (FDA) for the development of nanotechnology-based drugs. The global market for medical nanotechnology is expected to reach more than $3 billion (Sahoo et al., 2008) .
Glycyrrhizic acid (GA) is obtained from the roots of licorice plants (Glycyrrhiza glabra). It is a triterpene glycoside which presents active pharmacological and antimicrobial activity (Jianyuan et al., 2014) . It was found that Glycyrrhetinic acid can be produced in the human body through metabolic processes. The pharmacological effect of GA is similar to Glycyrrhetinic acid (Yong, 2012) . It was found that there are many useful secondary metabolites obtained such as alkaloids, saponins, and flavonoids due to the extraction of a Hydro-methanolic root (crude) from Glycyrrhiza glabra. All of these components are used as antibacterial and anti-oxidant ingredients (Sharma et al., 2013) .
This study was aimed to detect and identify extended spectrum β-lactamase (ESBL) producing K. pneumoniae strains from two hospitals in Egypt. The study is concerned with the identification of specific genes in charge of resistance to a β-lactam antibiotic group and the detection of their sequences. In addition, the effects of some antibiotics from different groups were investigated to overcome ESBL producing K. pneumoniae, and also the effect of different concentrations of Glycyrrhizic acid nanoparticle for preventing and controlling ESBL producing K. pneumoniae strains.
Materials and Methods

Clinical specimens
One hundred and fifty different clinical specimens were included in this study (eight were from pus samples, thirty from blood samples, twenty from urine samples and ninety two from sputum samples). They were collected from different hospital departments; 120 samples from Intensive Care Unit, Coronary Care Unit, medical laboratory and Surgery department of ElSadr Hospital and 30 samples from the medical laboratory of National Cancer Institute in Egypt from April 2016 to January 2017. The required documents were submitted and approved according to the committee guidelines showed by Central Directorate of Research and Health Development in Egypt. All samples were processed by standard methods (Cheesbrough, 2000 and Baveja, 2012) .
Ages of patients ranged from 20 to 60 years old. Both male and female patients were enrolled in this study to investigate the relationship between age, gender and prevalence of infection with K. pneumoniae.
Microbiological analysis
Bacterial identification and confirmation by API 20E test
The samples were cultured on blood agar and MacConkey's agar media (Lab M, United Kingdom) and incubated at 37°C for 24h. All clinical isolates were examined morphologically for colony characteristics on agar media (Archana & Harsh, 2011) . K. pneumoniae were isolated and purified on MacConkey's agar media. Biochemical standard procedures were used (Cruickshank, 1980 (Freeman et al., 2014) .
Antibiotic discs were placed on MullerHinton agar plates inoculated with 0.5 McFarland inoculum performed from overnight cultured isolates. Plates were incubated at 37ºC for 24h. Inhibition zone diameter was measured and compared to CLSI, 2014 criteria.
Detection of K. pneumoniae strains producing ESBL enzymes (ESBL screening)
The detection of ESBL producing K. pneumoniae strains was performed by using the Double Disk Synergy Test (DDST) as described
by Jailer et al. (1988) . Mueller Hinton agar plates were inoculated with a standardized inoculum of K. pneumoniae. Augmentin (20μg Amoxicillin and 10μg Clavulanic acid) disc was placed at the center of the inoculated plate. Three antibiotics from Cephalosporins 3 rd generation group (Cefotaxime 30μg, Ceftriaxone 30μg, Ceftazidime 30μg) and one Monobactam (Aztreonam 30μg) discs were placed at 20mm distance from Augmentin disc. Plates were incubated at 37 0 C for 24h. Positive results are indicated as an enhancing zone around the three combined antibiotics (Onur & Durak, 2009) .
Genotypic characterization Preparation of genomic DNA and PCR procedures
Total bacterial DNA was extracted using the QIAamp DNA Mini Kit (QIAGEN, USA). Template DNA of K. pneumoniae was prepared from freshly cultured isolates by culturing on 5ml brain heart broth medium at 37 0 C for 24h. After centrifugation for 10min at 7500rpm, the precipitate was resuspended in 180μl ATL buffer (tissue lysis) and 20μl proteinase K was added. After incubation at 56°C for 15min and centrifugation for 1min, 200μl buffer AL was added and further incubated at 70°C for 10min, 200μl ethanol 100% were added, then centrifuged for 1min. All microcentrifuge tubes were transferred to spin column, then centrifuged for 1min and discarded the tube containing the filtrate. At the last, 200μl AE (elution buffer) was added, incubated for 1min at room temperature and centrifuged for 1min. Extracted DNA was stored at -20ºC until PCR was performed (Rushdy et al., 2007 modified) .
Genotypic detection of bla genes by polymerase chain reaction (PCR)
Molecular detection of bla TEM and bla SHV were performed by using PCR analysis. Specific primers were designed for the detection of these genes (Metabion International AG, Germany) as shown in Table 1 .
PCR amplification was performed in 25μl master mix 2X concentration (5μl of 10X PCR buffer, 1.5mM MgCl 2 , 400μM dNTP, 1 unit Taq DNA polymerase), 2μl of each primer 10pmol/μl (Promega, USA), 5μl of the DNA extracted in a total volume of 50μl with sterile H 2 O DEPC treated. The cycling conditions for detection of bla TEM and bla SHV were done by Applied Biosystems Veriti 96-well Thermal Cycler (Puspanadan et al., 2013) . The PCR products were subsequently loaded onto 1.5% agarose gel (vivantis, USA) and electrophoresis was performed in 1 X TBE buffer at 100V for about 30min. The gels were then stained with 2μl ethidium bromide 10mg/ ml (Sigma, USA). DNA bands were visualized (UVPdual-intensity transilluminator, model: TM-20) at wavelength 312Nm and photographed by UVP-gel documentary system (Rushdy et al., 2007) .
Sequencing of DNA fragment
Sequencing was done using "ABI 3730xl DNA sequencer" and Sequence Analysis Software v3.1 in GATC Company, Germany. The sequences and homology of the two genes were done by Basic Local Alignment Search Tool (BLAST) and BLAST nucleotide (BLASTN 2.2.13) software and compared to GenBank database.
Preparation of Glycyrrhizic acid nanoparticle
One mg Glycyrrhizic acid (GA) solution (Xi'an fujie pharmaceutical Co, China) was added to 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide hydrochloride (Sigma-Aldrich, USA) and N-hydroxysuccinimide (SigmaAldrich, USA), they were dissolved in dimethylformamide (Amresco, USA). 2% chitosan was mixed with acetic acid and precipitated using acetone, then washed with 60% ethanol and ether. Then vacuum drying was done for the final product (Cheng et al., 2014) . Nano Glycyrrhizic acid was scanned by scanning electron microscope. Screening for antibacterial activity of different concentrations of Glycyrrhizic acid nanoparticle, a standard inoculum of multi-drug resistant K. pneumoniae bacterial isolate was subcultured on Mueller-Hinton agar (Oxoid, UK) and incubated at 37°C for 24h. (Cappuccino & Sherman, 1995) .
The lowest concentration of the antimicrobial agent which prevents the visible growth of a microorganism in a broth dilution susceptibility test is defined as minimal inhibitory concentration (MIC), while the minimal bactericidal concentration (MBC) was determined, after determining the results for the MIC, as the lowest concentration that achieved as 99.9% decrease in viable bacterial growth (Rushdy & Othman, 2011) . Different dilutions of Glycyrrhizic acid nanoparticles were prepared in 1% Dimethyl sulfoxide (DMSO) (10, 20, 30, 40, 50, 60, 70, 80, 90 and 100μg) . Wells were made using sterile borer and were loaded with 0.45μl of each concentration, then placed in incubator at 37 0 C overnight. The diameter of the inhibition zones was taken as a measure of the antibacterial activity (Othman & Hussein, 2015) .
Two tubes (one contained 2ml brain heart broth, 20μl bacterial suspension and 50μl Glycyrrhizic acid nanoparticles while the other tube was the control without Glycyrrhizic acid nanoparticles) were incubated in duplicates at 37°C for 24h. Bacterial growth was measured on spectrophotometer (T80 UV/VIS Spectrometer, United Kingdom) by optical density at 600nm.
Results
Eighty isolates out of the 150 (53.3%) collected from two different hospitals were identified as K. pneumoniae in the period from April 2016 to January 2017. Four were isolated from pus, 15 from blood, 10 from urine and 51 from sputum samples. These isolates were first morphologically identified as large dome-shaped colonies on Blood, lactose fermenting mucoid colonies on MacConkey agar plates. Biochemical characteristics of these isolates were performed by analytical profile index (API 20E) where positivity for o-nitrophenyl-β-Dgalactoside, Lysine Decarboxylase, Citrate Test, Urease Test, Voges-Proskauer Test and sugar (Glucose, Sorbitol, Mannitol,Rhamnose, Inositol, Sucrose, Arabinose, Melibiose and Amygdalin) fermentation. The clinical specimens collected from different hospital units are shown in Table 2 . Fifty isolates (62%) out of 80 Klebsiella pneumoniae were from males and 30 (38%) were from females. Figure 1 shows the distribution of Klebsiella pneumoniae infection in different age groups and Fig. 2 shows the distribution of Klebsiella pneumoniae infection in relation to patient sex and type of specimen.
The antibiotic susceptibility testing of the eighty K. pneumoniae isolates showed high susceptibility to Carbapenems (Imipenem 88.75% and Meropenem 88.75), Chloramphenicol 96.25%, Aminoglycosides (Amikacin 68.75% and Gentamycin 73.75%), Trimethoprim/ Sulphamathoxazole 62.5% and Quinolones (Ciprofloxacin 60%). On the other hand, K. pneumoniae strains were found to be highly resistant to Penicillin group (Ampicillin 86.25%, Piperacillin 62.5% and Amoxicillin/ Clavulanic acid 81.25%), Cephalosporins group (Cefaclor85%, Ceftazidime 92.5% and Ceftriaxone 100%), Quinolones group (Nalidixic acid 68.75%) and Rifampin 100% (Fig. 3) .
Seventy one percent (57/80) isolates of K. pneumoniae were found to be multi-drug resistant strains and 63% (36/57) also found to contain the ESBL enzymes, so they were tested by double disk synergy test for the production of extendedspectrum β-lactamases (Table 3 and Fig. 4) . The figure illustrates double-disk synergy test for amoxicillin/clavulanic acid 20/10μg, ceftazidime 30μg, cefotaxime 30μg, ceftriaxone 30μg and aztreonam 30μg.
Genotypic analysis for bla TEM and bla SHV genes by polymerase chain reaction. The 36 multi-drug resistant K. pneumoniae isolates which were ESBL positive subjected to the detection of TEM and SHV genes. Genotypic characterization by PCR revealed presence of bla TEM and bla SHV genes at 478bp and 606bp, respectively ( Fig. 5 and 6 ). Nineteen isolates out of 36 (52.8%) harbored TEM geneand 26 isolates (72.2%) harbored SHV gene, while nine isolates out of the 36 ESBL producing K. pneumoniae isolates (25%) harbored both genes. Nucleic acid sequencealignment of bla TEM and bla SHV genes for the Egyptian K. pneumoniae isolates was done on gene bank database on the World Wide Web and revealed the presence of some mutations. Table 4 illustrated three types of mutations in bla TEM including deletion, substitution and insertion, while in case of bla SHV gene there were two types of mutations including deletion and substitution (Table 5) .
Effect of Glycyrrhizic acid nanoparticles on ESBL producing Klebsiella pneumoniae, different concentrations of Glycyrrhizic acid nano-particle were tested for their antibacterial activity on three ESBL producing K. pneumoniae isolates, one contains TEM gene, one contains SHV gene and one contains both genes. Nano Glycyrrhizic acid was scanned by scanning electron microscope (Fig. 7 ).
The Table 6 shows that the minimal bactericidal concentration (MBC) for the bacterial isolates which contain both TEM or SHV genes and that containing both genes was 10µg/ml Nano Glycyrrhizic acid. The minimal inhibitory concentration (MIC) for the isolate that contains TEM gene was 20µg/ml and that for the isolate contains SHV gene was 40µg/ml while that for the isolate containing both genes was 30µg/ml. 
Discussion
The present study reveals that K. pneumoniae was detected in 53.3% of the total collected samples. Seventy one percent of them were found to be multi-drug resistant strains. Conversely to this result, Archana & Harsh (2011) illustrated that11.8% confirmed K. pneumoniae isolates were further tested for antimicrobial drug sensitivity and almost fifty percent of them were found to be multidrug resistant. A possible subtle difference with 'non-Egyptian' isolates of K. pneumonia that patients neglect the time and right dose of treatment and take medication without consulting the doctor until bacterial genes develop resistance.
In the present study, Klebsiella pneumoniae isolates was predominant in males (62%) than in females (38%). K. pneumoniae infection seen in patients aged 20-60. Conversely, to this result Shashidhar Vishwanath et al. (2013) illustrated that the high percentage of infection in patients admitted to Iran hospital were females with a percentage (45.45%) than males (31.57%), Klebsiella pneumoniae infection seen in persons aged 45-60. This may be due to the Egyptian Traditions is that females are used to stay at home so they are protected from infection while males are responsible for working and may have bad habits like smoking.
The current study indicated that non ESBL producing K. pneumoniae isolates were found to be highly susceptible to Carbapenems (imipenem 88.75% and meropenem 88.75), chloramphenicol 96.25%, Aminoglycosides (amikacin 68.75% and gentamycin 73.75%), Trimethoprim/ Sulphamathoxazole 62.5% and Quinolones (ciprofloxacin 60%). On the other hand, ESBL producing K. pneumoniae isolates were found to be highly susceptible to Carbapenems (imipenem 75.0% and meropenem 75.0), chloramphenicol 91.7% and aminoglycosides (amikacin 41.7% and gentamycin 50.0%).
In previous studies, K. pneumoniae strains were found to be highly susceptible to aminoglycosides and quinolones. On the other hand over 60% strains were resistant to chloramphenicol, tetracycline and cephalosporins (ceftizoxime and cefotaxime). Cephalosporins were the drug of choice in combination with aminoglycosides to treat Klebsiella infection (Archana & Harsh, 2011) . Carbapenems are stable in the presence of hydrolytic effects of ESBLs, which may explain the consistent finding that >98% of ESBLproducing organisms retain susceptibility to either imipenem or meropenem (Babini & Livermore, 2000; Goossens, 2001 and Winokur et al., 2001 ).
The present study showed that 36 isolates of K. pneumoniae out of eighty bacterial isolates were found to be ESBL producing K. pneumoniae (sputum n=26 and blood n=10). They also showed a positive result for double disk synergy test for the production of extended spectrum β-lactamases. These ESBL multi-drug resistant K. pneumoniae were found to be highly resistance to Lahlaoui et al., 2014) . The chromosomally encoded β-lactamases could be responsible for this intrinsic resistance (Sahly et al., 2004) . Overall resistance was high on account of the production of extended spectrum β-lactamases (ESBLs) by the K. pneumoniae.
ESBLs are grouped into four classes A, B, C and D enzymes. Temoneira (TEM) and sulfhydryl variable (SHV) are class A ESBLs (Shahid et al., 2011) . The most common ESBLs observed in the isolated K. pneumoniae plasmids are encoding Temoniera (TEM) and Sulfhydryl variable (SVH), which are active against Cephalosporins (Vuotto et al., 2014) so in the present study, PCR was performed to determine the presence of TEM and SHV genes as antibiotic resistance factors of K. pneumoniae.
Plasmids encoding Temoniera (TEM) and
Sulfhydryl variable (SVH) ESBLs are the most common to be found in isolated K. pneumoniae, which are active against cephaloporins. The plasmids that encode the ESBL genes also have been found to carry genes that express resistance for drugs other than beta-lactams, such as aminoglycosides (Vuotto et al., 2014) . So in this study the detection TEM and SHV genes was used as a mark of multi-drug resistant in K. pneumoniae.
The results indicated that 52.8% contained the TEM gene and 72.2% contained the SHV gene, while 25% of the multi-drug resistant isolated has both genes (TEM and SHV). Multidrug-resistant (MDR) and extended-spectrum β-lactamase producing Klebsiella pneumoniae pose serious antibiotic management problem as resistance genes are easily transferred from one organism to another (Lim et al., 2009 ). Fouzia & Damle (2015) made a study on the amplification of bla TEM and bla SHV and she found that seventy percent of isolates showed a presence of TEM gene, while 50% isolates showed a presence of SHV gene and 20% isolates had both bla TEM and bla SHV genes.
In a study by Amita Jain & Rajesh Mondal using the same set of primers, they found a presence of bla TEM gene in ESBL producing Klebsiella sp. as more common (48.4 %) than bla SHV (20.3%) gene. while (26.5%) isolates presented both TEM and SHV genes (Jain & Mondal, 2008) .
The present study revealed that sequencing alignment of bla TEM and bla SHV genes showed some mutations in both genes such as deletion and substitution in both genes and insertion in TEM gene only. The mutation presented in both genes may be due to the excess or improper use of antibiotics in Egypt.
Glycyrrhizic acid interferes with arylamine N-acetyltransferase activity in bacteria, thus showing antibacterial effects against Klebsiella spp. (Tanaka et al., 2001 and Krausse et al., 2004) .
Glycyrrhizic acid should be considered, one of the proposed chemopreventive drugs, that could inhibit arylamine N-acetyltransferase (NAT) activity in Klebsiella pneumoniae. The NAT activity in K. pneumoniae was inhibited by Glycyrrhizic acid in a dose-dependent manner (Hsueh-Hsia et al., 1997) .
Conclusion
The present study showed that nano Glycyrrhizic acid was found to be highly effective on MDR K. pneumoniae. The minimal inhibitory concentration (MIC) for the isolate that contains TEM gene was 20% and that for the isolate contains SHV gene was 40% while that for the isolate containing both genes was 30%.
